3 Pharmaceutical Stocks to Buy Hand Over Fist in March
Pharmaceutical companies play a tremendous role in modern healthcare. While sometimes controversial, drugmakers design medicine to treat some of the worst ailments plaguing society and constantly innovate to improve human life.
Their long-term relevance in healthcare makes the pharmaceutical business an excellent place for investors to find long-term investment ideas. These three stocks offer investors a mix of solid financials, long-term upside, and passive income.
(NYSE: PFE) is a mainstay in the pharmaceutical space. The company has been around for decades and has shifted multiple times with blockbuster acquisitions. Most recently, Pfizer became a leading vaccine company during the COVID-19 pandemic, generating tremendous revenue from Comirnaty and Paxlovid. However, those sales fell off as the pandemic passed, which soured Wall Street on Pfizer's growth outlook. The stock has fallen a whopping 55% from its high.
Source Fool.com
Pfizer Inc. Aktie
Die Pfizer Inc. Aktie steht gut da: Deutlich mehr Buy- als Sell-Einschätzungen in der Community.
Das Kursziel von 41 € für Pfizer Inc. impliziert eine deutliche Steigerung um über 50% gegenüber 25.77 €.
